PNDA 12.38M US ADR:N
PNDA Biosciences (fictional) Biotechnology
FLOAT F : 3.20M
D : 3.20M
INST OWN
6.2%
INSIDER
11.6%
ROTATION
15.1x
SHORT INT
9.4%
SPLIT (74d ago)
⚠ R/S ↑ 20:1
Overall Dilution Risk High
OfferingMedium
HistHigh
SupplyHigh
Cash NeedHigh
Est Cash$2.9M
Burn Rate-$2.6M
Cash Left3.3 mo
GC NASDAQTrue / True
DILUTION INSTRUMENTS
Warrants:$4.50 - 1.2M - 28-07-31
Warrants:$9.60 - 0.4M - 02-05-30
Warrants:(+2 >10x price)
Convert:$2.80 - 0.54M - 15-12-26
Shelf:ACT S-3 $2.2M/$150.0M 11-06-29
ATM:ACT $7.9M/$10.0M
🤖 PANDA AI 30m ago ⟳
WHY STOCK MOVING ✓ CATALYST
Preclinical PR lifts a post-R/S biotech four days after its ATM was re-armed
Move is PR-driven: mouse-model data, no human data, no... show more
EDGE: The ATM line reads $7.9M left, but the binding number is the $2.2M I.B.6 room: at $3.42 that is ~0.64M shares, 20% of the float, and 15x rotation gives the agent the volume to place it. Proof of sales arrives only with the Q3 10-Q or a new 424B5.
FILINGS 🤖 PANDA AI (6)
8-KItem 8.01 - PNDA-201 preclinical data press release2h▼ AI
424B5ATM prospectus supplement sized to the I.B.6 room4d▼ AI
8-KItem 3.01 - Nasdaq notice: stockholders' equity below $2.5M32d▼ AI
EFFECTresale S-1 for the July PIPE declared effective38d▼ AI
10-QQ2 - ATM sold 0.62M shares for $2.10M; going-concern language45d▼ AI
8-KItems 1.01/3.02 - $3.3M PIPE with Series A warrants59d▼ AI
NEWS(3)
PRODUCTGLOBEN2hPNDA Biosciences Reports Preclinical Data for P...AI: Preclinical only — and it lands four days after a fresh ATM supplement.
PIPE DEALPR NEW59dPNDA Biosciences Announces $3.3 Million Private...AI: 1:1 warrant coverage at $4.50; resale registration follows.
REVERSE SPLITGLOBEN78dPNDA Biosciences Announces 1-for-20 Reverse Sto...AI: Split to keep the $1 bid; authorized shares not reduced.
• 30m ago🔄 Reload
▸PLAYATM DRIPEARLY STAGE
▸HIDDEN LEVELS4.50 - 3.39 - 2.80 - 2.75
▸NARRATIVE
▸TIMELINE